Morrell M. Avram Livres

The book explores the intersection of prevention strategies and the costly treatment of uremia, highlighting the complexities faced by patients who have survived a once-fatal condition. It discusses the significant financial burden placed on healthcare systems, particularly in the U.S., where a small percentage of patients consume a large portion of Medicare resources. The text also addresses ethical dilemmas in treatment selection, especially in resource-limited settings, and presents findings from a conference focused on the long-term survival of treated uremic patients.